Results 21 to 30 of about 13,816 (168)

Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis

Frontiers in Neurology, 2022
Liposomal amphotericin B (L-AMB) is an anti-fungus medicine that has fewer side effects than traditional amphotericin B (AMB). Neurotoxicity of L-AMB has rarely been observed, and only one case of leukoencephalopathy during intravenous L-AMB has been ...
Si Luo, Han Wen, Meihong Zhou, Chengsi Wu, Daojun Hong   +4 more
doaj   +1 more source

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?

Allergy, Asthma & Clinical Immunology, 2021
Allergic reaction to liposomal amphotericin B is rare. We report a case of cardiac arrest in a 64-year-old woman following liposomal amphotericin B infusion, requiring resuscitation.
George P. Drewett, Ana Copaescu, Joseph DeLuca, Natasha E. Holmes, Jason A. Trubiano   +4 more
doaj   +1 more source

Disseminated Histoplasmosis in HIV-Infected Patients: A Description of 34 Years of Clinical and Therapeutic Practice

Journal of Fungi, 2020
Disseminated histoplasmosis is the main AIDS-defining infection of French Guiana. We aim to describe our therapeutic experience for 349 patients with disseminated histoplasmosis between 1 January 1981 and 10 January 2014 in French Guiana.
Mathieu Nacher, Audrey Valdes, Antoine Adenis, Romain Blaizot, Philippe Abboud, Magalie Demar, Félix Djossou, Loïc Epelboin, Caroline Misslin, Balthazar Ntab, Kinan Drak Alsibai, Pierre Couppié   +11 more
doaj   +1 more source

Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal Meningitis [PDF]

Clinical Infectious Diseases
Sarah Kimuda, Jane Frances Ndyetukira, Tony Luggya   +2 more
exaly   +2 more sources

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report

Journal of Medical Case Reports, 2022
Background Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects immunocompromised hosts.
Shuku Sato, Wataru Kamata, Kiyomitsu Fukaguchi, Shun Tsunoda, Tadashi Kamio, Hiroshi Koyama, Hideyasu Sugimoto, Yotaro Tamai   +7 more
doaj   +1 more source

Persistent dyselectrolytemia in a neonate induced by liposomal amphotericin B. A case report

Frontiers in Pediatrics, 2023
BackgroundNephrotoxicity is the most frequent serious adverse effect associated with amphotericin B deoxycholate treatment, for this reason, in recent years it has been relegated from routine clinical practice and replaced by the new liposomal ...
Adrian Puertas Sanjuan, Carlos Javier Parramón-Teixidó, Susana Hernandez-Perez, Marie Antoinette Frick, Maria Jose Cabañas Poy   +4 more
doaj   +1 more source

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

Medical Mycology Case Reports, 2017
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi, Yuta Katayama, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Shinya Katsutani, Koji Iwato, Hideki Asaoku   +8 more
doaj   +1 more source

Potency and stability of liposomal Amphotericin B formulated for topical management of Aspergillus spp. infections in burn patients

Burns Open, 2020
Background: Systemic fungal infections are an important mortality factor when considering severely burned patients. Preventive topical pharmacotherapeutic management of deep fungal infections remains of secondary concern when initially treating a burn ...
Alexis Laurent, Olivier Pantet, Lydie Laurent, Nathalie Hirt-Burri, Anthony de Buys Roessingh, Wassim Raffoul, Philippe Laurent, Michel Monod, Lee Ann Applegate   +8 more
doaj   +1 more source

Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil

Revista da Sociedade Brasileira de Medicina Tropical, 2019
INTRODUCTION: Visceral leishmaniasis (VL) is fatal if not diagnosed and treated. This study aimed to estimate the cost-effectiveness of diagnostic-therapeutic alternatives for VL in Brazil.
Tália Santana Machado de Assis, Ana Rabello, Gláucia Cota, Guilherme Loureiro Werneck, André Luís Ferreira de Azeredo-da-Silva   +4 more
doaj   +1 more source

HIV-associated disseminated histoplasmosis successfully treated with isavuconazole consolidation therapy

Medical Mycology Case Reports, 2020
A 30-year-old man with advanced HIV and disseminated histoplasmosis deteriorated after stepping down from intravenous liposomal amphotericin B to itraconazole.Therapeutic levels of itraconazole and posaconazole were not achieved, therefore liposomal ...
Andrea Mazzella, Neil R.H. Stone, Erica R.M. Pool, Ana García Mingo, Sorina Bolache, Chris Wood   +5 more
doaj   +1 more source